Cargando…
Leveraging FPR2 Agonists to Resolve Inflammation and Improve Outcomes Following Myocardial Infarction
[Figure: see text]
Autores principales: | Koenig, Andrew L., Lavine, Kory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385647/ https://www.ncbi.nlm.nih.gov/pubmed/34466755 http://dx.doi.org/10.1016/j.jacbts.2021.07.009 |
Ejemplares similares
-
Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction
por: García, Ricardo A., et al.
Publicado: (2021) -
Eosinophils Confer Protection Following Myocardial Infarction
por: Lavine, Kory J.
Publicado: (2020) -
Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction
por: Ali, Muhammad, et al.
Publicado: (2016) -
Increased Afterload Following Myocardial Infarction Promotes Conduction-Dependent Arrhythmias That Are Unmasked by Hypokalemia
por: Motloch, Lukas J., et al.
Publicado: (2017) -
Micro RNA-411 Expression Improves Cardiac Phenotype Following Myocardial Infarction in Mice
por: Nugroho, Ardiansah Bayu, et al.
Publicado: (2022)